GlassScriptPhysician profile
Mariela Sandi
NPI 1407227556
$6,651.54
in general payments reported to CMS, 2019-2025
42 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,140 · 2022: $1,680 · 2023: $1,222 · 2024: $490 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,732 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,731.90 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $1,103.27 | 2021-2022 | |
| Janssen Biotech, INC. | $783.70 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $553.11 | 2021-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $481.54 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $373.00 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $354.88 | 2023-2025 | Gemtesa |
| Kerecis Limited | $338.72 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Antares Pharma, INC. | $300.29 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Myriad Genetic Laboratories, INC. | $212.76 | 2022-2025 | Myrisk, Prolaris |
| Endo Pharmaceuticals INC. | $203.73 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $184.69 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $166.07 | 2023 | |
| Urovant Sciences INC | $155.75 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $113.73 | 2022-2024 | Lynparza |
| Pfizer INC. | $112.86 | 2021-2023 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariela Sandi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.